Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Clinical trial NCT00765856 · TERMINATED
Trial details
- NCT number
- NCT00765856
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-17
- Primary completion
- 2010-02-22
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.